# Vanita Noronha

Source: https://onco.cc/people/noronha-vanita/  
OnCo record `noronha-vanita` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A medical oncologist who co-leads Tata Memorial's lung cancer trials and built India's geriatric oncology programme.

## Summary

Vanita Noronha is Professor of Medical Oncology at Tata Memorial Hospital, part of the Tata Memorial Centre in Mumbai, working in geriatric oncology and lung cancer. She co-leads the hospital's lung cancer trials and co-led the trial of gefitinib with or without pemetrexed and carboplatin chemotherapy in EGFR-mutant lung cancer. She also built India's geriatric oncology programme, establishing a geriatric oncology clinic and research programme based on geriatric assessment. Her interests are lung cancer, geriatric oncology, head and neck cancer and clinical trials.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Professor of Medical Oncology, Tata Memorial Hospital; geriatric oncology and lung cancer
- Specialisms: Lung cancer; Geriatric oncology; Head and neck cancer; Clinical trials

## Sources

- Tata Memorial Centre: https://tmc.gov.in
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Noronha%20V%5BAuthor%5D%20Tata%20Memorial%20lung

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [Geriatric assessment](https://onco.cc/technologies/geriatric-assessment/)
- institutions: [Tata Memorial Centre](https://onco.cc/institutions/tata-memorial/)
- trials: [Gefitinib vs gefitinib plus pemetrexed-carboplatin in EGFR-mutant lung cancer (Tata Memorial)](https://onco.cc/trials/gefitinib-chemo-tmh/), [Low-dose nivolumab plus metronomic chemotherapy (Tata Memorial)](https://onco.cc/trials/low-dose-nivolumab-tmh/), [Oral metronomic chemotherapy vs intravenous cisplatin (Tata Memorial)](https://onco.cc/trials/metronomic-vs-cisplatin-tmh/)
- key papers: [Low-dose immunotherapy in head and neck cancer: a randomised study (Tata Memorial)](https://onco.cc/key-papers/paper-patil-low-dose-nivolumab-jco-2023/)

---
JSON: https://onco.cc/api/v1/entities/noronha-vanita.json